Entasis Therapeutics Holdings Inc. ETTX
2.19 +2.19
Day range unavailable
52-week range unavailable
News
https://www.businesswire.com Zai Lab and Innoviva Specialty Therapeutics Announce NMPA Approval for XACDURO® (Sulbactam-Durlobactam or SUL-DUR) for Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Acinetobacter Baumannii-Calcoaceticus Complex in China SHANGHAI & CAMBRIDGE, Mass. & WALTHAM, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) and Innoviva Specialty Therapeutics today announced that China’s National Medical Products…
businesswire.com Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc. BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”) today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of Entasis…
businesswire.com Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc. BURLINGAME, Calif.--(BUSINESS WIRE)--Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”) today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of Entasis…
businesswire.com Scott+Scott Attorneys at Law LLP Investigates Innoviva Buyout of Entasis – ETTX NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the directors of Entasis…
businesswire.com Scott+Scott Attorneys at Law LLP Investigates Innoviva Buyout of Entasis – ETTX NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the directors of Entasis…
prnewswire.com ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Entasis Therapeutics Holdings Inc. NEW YORK , May 24, 2022 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX) and its board of directors concerning…
zacks.com Entasis (ETTX) Stock Rises on Buyout Offer From Innoviva Innoviva (INVA) is set to acquire Entasis (ETTX) for $2.20 per share in cash. The transaction is likely to close by third-quarter 2022.
businesswire.com ENTASIS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Entasis Therapeutics Holdings Inc. - ETTX NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Entasis…
businesswire.com ETTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Entasis Therapeutics Holdings Inc. Is Fair to Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX) to Innoviva, Inc. for $2.20 per share…
benzinga.com Innoviva Acquires AstraZeneca-Spin Off At $2.20/Share Innoviva Inc (NASDAQ: INVA) has agreed to acquire Entasis Therapeutics Holdings Inc (NASDAQ: ETTX) at $2.20 per share in cash. Innoviva currently owns approximately 60% of the outstanding shares of…
businesswire.com Innoviva to Acquire Entasis Therapeutics BURLINGAME, Calif. & WALTHAM, Mass.--(BUSINESS WIRE)--Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative…
businesswire.com Innoviva to Acquire Entasis Therapeutics BURLINGAME, Calif. & WALTHAM, Mass.--(BUSINESS WIRE)--Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative…
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022 Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last…
investorplace.com Wednesday Top Stock News: 8 Analyst Upgrades and Downgrades Today We're taking a look at the top stock news for Wednesday and that includes the latest analysts upgrades and downgrades you need to know about! The post Wednesday Top Stock News: 8 Analyst Upgrades and…
seekingalpha.com Entasis Therapeutics Holdings Inc. (ETTX) CEO Manoussos Perros on Q3 2021 Results - Earnings Call Transcript Entasis Therapeutics Holdings Inc. (ETTX) CEO Manoussos Perros on Q3 2021 Results - Earnings Call Transcript
benzinga.com Earnings Scheduled For November 4, 2021 Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
globenewswire.com Entasis Therapeutics announces positive topline results for sulbactam-durlobactam (SUL-DUR) from Phase 3 ATTACK trial WALTHAM, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (Nasdaq:ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel…
globenewswire.com Entasis Therapeutics to Participate in the Cantor Fitzgerald Virtual Global Healthcare Conference WALTHAM, Mass., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel…
pennystocks.com Making Money With Penny Stocks During a Stock Market Crash Trading penny stocks in a down market? Here's three tips and tricks to use in your search The post Making Money With Penny Stocks During a Stock Market Crash appeared first on Penny Stocks to Buy,…
benzinga.com Why Are Entasis Therapeutics Shares Moving Higher On Thursday? Entasis Therapeutics Holdings Inc (NASDAQ: ETTX) stock is up sharply after the journal Nature published an article on the potential of its preclinical candidate ETX0462, which could become the first…
globenewswire.com Profile of Entasis Therapeutics ETX0462 Candidate Published in the Journal Nature Publication Details the Discovery and Preclinical Profile of ETX0462, a First-in-Class Candidate Against Multidrug-Resistant Pathogens Publication Details the Discovery and Preclinical Profile of…
benzinga.com Stocks That Hit 52-Week Lows On Thursday Before 10 a.m. ET Thursday, 104 stocks made new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's morning trading, 129 companies set new 52-week lows. Areas of Interest: The largest company in terms of market cap to set a new 52-week low was Wells Fargo (NYSE: WFC).
benzinga.com 34 Stocks Moving in Monday's Pre-Market Session Gainers Midatech Pharma plc (NASDAQ: MTP) rose 34% to $2.68 in pre-market trading after the company disclosed headline results of MTX110 Phase I DIPG study.- benzinga.com 38 Stocks Moving in Friday's Pre-Market Session Gainers ReWalk Robotics Ltd. (NASDAQ: RWLK) rose 50% to $1.74 in pre-market trading after declining over 6% on Thursday. Traders circulated an August 27th press release that highlighted the US Court…
benzinga.com 65 Biggest Movers From Yesterday Gainers Urban One, Inc. (NASDAQ: UONE) shares jumped 255.4% to close at $6.54 on Monday after surging around 22% on Friday.
benzinga.com 115 Biggest Movers From Yesterday 
benzinga.com Stocks That Hit 52-Week Lows On Monday 
benzinga.com Stocks That Hit 52-Week Lows On Friday - benzinga.com Stocks Which Set New 52-Week Low Today, Wed., Jan. 2, 2019
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018
- benzinga.com Stocks Which Set New 52-Week Low Friday, October 26th
benzinga.com Stocks Which Set New 52-Week Low Friday, October 5th - benzinga.com Stocks Which Set New 52-Week Low Yesterday, October 3rd
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, October 2nd